These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6127980)

  • 1. A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants.
    Duggan MA; Court JB
    Ann Clin Res; 1981 Dec; 13(6):406-18. PubMed ID: 6127980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lymphadenopathies caused by drugs].
    Krasznai G; Szegedi G
    Orv Hetil; 1969 Nov; 110(48):2797-802. PubMed ID: 4903568
    [No Abstract]   [Full Text] [Related]  

  • 3. Is phenytoin carcinogenic?
    Lancet; 1971 Nov; 2(7733):1071-2. PubMed ID: 4106919
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between some anticonvulsants and tumors of the blood forming organs.
    Bercel NA; Henstell HH
    Bull Los Angeles Neurol Soc; 1970 Jan; 35(1):21-4. PubMed ID: 5411538
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydantoin induced lymphadenopathy. A case of report.
    Murthy JM; Chopra JS; Gupta R; Sehgal S; Mohanty D
    Neurol India; 1978 Mar; 26(1):38-40. PubMed ID: 683424
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphadenopathy resulting from long-term use of hydantoin.
    Szegedi G; Krasznai G; Sorszegi P; Szabó G
    Acta Med Acad Sci Hung; 1970; 27(3):243-51. PubMed ID: 5511166
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of phenytoin hypersensitivity syndrome.
    Monks G; Crowson AN; Cornelison R; Naylor M
    J Drugs Dermatol; 2002 Sep; 1(2):199-201. PubMed ID: 12847747
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effects of different beta-blocking agents against electroshock lethality in mice.
    Pérez-Ojeda E; Hernandez J; Serrano JS
    J Pharmacol; 1983; 14(3):303-9. PubMed ID: 6138460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hydantoin-induced lymphadenopathy].
    Celikic S
    Srp Arh Celok Lek; 1973 Feb; 101(2):173-7. PubMed ID: 4207031
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoriasis provoked by beta-blocking agents.
    Arntzen N; Kavli G; Volden G
    Acta Derm Venereol; 1984; 64(4):346-8. PubMed ID: 6209897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic action of beta-adrenergic blocking drugs: pronethalol and propranolol.
    Dashputra PG; Patki VP; Hemnani TJ
    Mater Med Pol; 1985; 17(2):88-92. PubMed ID: 2867256
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenytoin antagonism of electrically induced maximal seizures in frogs and mice and effects on central nervous system levels of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.
    Johnson SW; Riker WK
    J Pharmacol Exp Ther; 1982 Apr; 221(1):139-45. PubMed ID: 6278134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin and generalized lymphadenopathy.
    Harris NL; Widder DJ
    Arch Pathol Lab Med; 1983 Dec; 107(12):663-4. PubMed ID: 6688948
    [No Abstract]   [Full Text] [Related]  

  • 14. Side-effects of beta-adrenergic blocking drugs in asthmatics.
    Beumer HM; Hardonk HJ
    Indian Heart J; 1972 Jun; 24():Suppl 1:226-30. PubMed ID: 4147277
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Phenytoin-induced lymphadenopathy.
    Archer JD
    Arch Otolaryngol; 1975 Aug; 101(8):461. PubMed ID: 1156229
    [No Abstract]   [Full Text] [Related]  

  • 16. [Side effects of beta adrenergic blocking drugs -- a methodological problem (author's transl)].
    Dany F; Bordes MM; Dallocchio M; Albin H; Dangoumau J; Merle L; Charmes JP; Brosset P
    Therapie; 1980; 35(3):381-9. PubMed ID: 6106970
    [No Abstract]   [Full Text] [Related]  

  • 17. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
    Eliasson K; Danielson M; Hylander B; Lindblad LE
    Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin and the pseudolymphoma syndrome.
    Oates RK; Tonge RE
    Med J Aust; 1971 Aug; 2(7):371-3. PubMed ID: 5092894
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphadenopathy associated with diphenylhydantoin therapy.
    Abratt RP; Sealy R; Uys CJ; Lawson R
    Clin Oncol; 1982 Dec; 8(4):351-6. PubMed ID: 7168928
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenytoin-induced benign lymphadenopathy with solid spleen lesions mimicking a malignant lymphoma.
    Rodríguez-García JL; Sánchez-Corral J; Martínez J; Bellas C; Aguado M; Serrano M
    Ann Oncol; 1991 Jun; 2(6):443-5. PubMed ID: 1768633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.